New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.
about
New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
New metformin derivative HL156 ...... target of rapamycin pathways.
@en
New metformin derivative HL156 ...... target of rapamycin pathways.
@nl
type
label
New metformin derivative HL156 ...... target of rapamycin pathways.
@en
New metformin derivative HL156 ...... target of rapamycin pathways.
@nl
prefLabel
New metformin derivative HL156 ...... target of rapamycin pathways.
@en
New metformin derivative HL156 ...... target of rapamycin pathways.
@nl
P2860
P356
P1433
P1476
New metformin derivative HL156 ...... target of rapamycin pathways.
@en
P2093
Yun Soo Jeong
P2860
P304
P356
10.1111/CAS.13482
P577
2018-01-27T00:00:00Z